Subject    :    [2017 Apr;41(2)] Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance
Writer KDA
Date 2017-07-06 10:58:54 Hit 7,120
Diabetes Metab J. 2017 Apr;41(2):89-95. English.
Published online Nov 15, 2016.  https://doi.org/10.4093/dmj.2017.41.2.89 
Copyright © 2017 Korean Diabetes Association
   
Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance
Yu Mi Kang,1 Francis Kim,2 and Woo Je Lee1
1Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
2Department of Medicine, Diabetes and Obesity Center of Excellence, University of Washington, Seattle, WA, USA.

Corresponding author: Woo Je Lee. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Email: lwjatlas@amc.seoul.kr 
 
Received September 08, 2016; Accepted October 26, 2016.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

 
Abstract

Obesity has quickly become a worldwide pandemic, causing major adverse health outcomes such as dyslipidemia, type 2 diabetes mellitus, cardiovascular disease and cancers. Obesity-induced insulin resistance is the key for developing these metabolic disorders, and investigation to understand the molecular mechanisms involved has been vibrant for the past few decades. Of these, low-grade chronic inflammation is suggested as a critical concept in the development of obesity-induced insulin resistance, and the anti-inflammatory effect of nitric oxide (NO) signaling has been reported to be linked to improvement of insulin resistance in multiple organs involved in glucose metabolism. Recently, a body of evidence suggested that vasodilatory-stimulated phosphoprotein (VASP), a downstream mediator of NO signaling plays a crucial role in the anti-inflammatory effect and improvement of peripheral insulin resistance. These preclinical studies suggest that NO/VASP signaling could be an ideal therapeutic target in the treatment of obesity-related metabolic dysfunction. In this review, we introduce studies that investigated the protective role of NO/VASP signaling against obesity-related inflammation and insulin resistance in various tissues.

   
Keywords:
Adipose tissue; Chronic inflammation; Endothelium, vascular; Insulin resistance; Liver; Macrophages; Nitric oxide; Obesity; Vasodilator-stimulated phosphoprotein

Articles - Reviews in DMJ
No. Subject Date Hit ↓
Notice : [2017 Oct;41(5)] Generation of Insulin-Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD [2017 Oct;41(5)] Generation of Insulin-Expressing Cells in Mouse Sma... 2018-12-03 158
Notice : [2017 Oct;41(5)] Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data [2017 Oct;41(5)] Features of Long-Standing Korean Type 2 Diabetes Me... 2018-12-03 166
Notice : [2017 Oct;41(5)] Performance of the Achutha Menon Centre Diabetes Risk Score in Identifying Prevalent Diabetes in Tamil Nadu, India [2017 Oct;41(5)] Performance of the Achutha Menon Centre Diabetes Ri... 2018-12-03 148
Notice : [2017 Oct;41(5)] Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks [2017 Oct;41(5)] Effects of Lobeglitazone, a Novel Thiazolidinedione... 2018-12-03 173
Notice : [2017 Oct;41(5)] Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017 [2017 Oct;41(5)] Insulin Therapy for Adult Patients with Type 2 Diab... 2018-12-03 140
Notice : [2017 Oct;41(5)] Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus [2017 Oct;41(5)] Combination Therapy of Oral Hypoglycemic Agents in ... 2018-12-03 153
Notice : [2017 Oct;41(5)] Monotherapy in Patients with Type 2 Diabetes Mellitus [2017 Oct;41(5)] Monotherapy in Patients with Type 2 Diabetes Mellit... 2018-12-03 163
Notice : [2017 Oct;41(5)] Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association [2017 Oct;41(5)] Antihyperglycemic Agent Therapy for Adult Patients ... 2018-12-03 157
Notice : [2017 Oct;41(5)] Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy Metabolism [2017 Oct;41(5)] Skeletal Muscle Thermogenesis and Its Role in Whole... 2018-12-03 143
Notice : [2017 Aug;41(4)] Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4 [2017 Aug;41(4)] Factors Associated with Improved Glycemic Control b... 2018-12-03 150
Notice : [2017 Aug;41(4)] In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells [2017 Aug;41(4)] In Vitro Effect of Fatty Acids Identified in the P... 2018-12-03 160
Notice : [2017 Aug;41(4)] Depression and Mortality in People with Type 2 Diabetes Mellitus, 2003 to 2013: A Nationwide Population-Based Cohort Study [2017 Aug;41(4)] Depression and Mortality in People with Type 2 Diab... 2018-12-03 158
Notice : [2017 Aug;41(4)] Determinants of Long-Term Durable Glycemic Control in New-Onset Type 2 Diabetes Mellitus [2017 Aug;41(4)] Determinants of Long-Term Durable Glycemic Control ... 2018-12-03 155
Notice : [2017 Aug;41(4)] Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea [2017 Aug;41(4)] Effects of High-Dose α-Lipoic Acid on Heart Rate ... 2018-12-03 154
Notice : [2017 Aug;41(4)] Comparison of Glucose Area Under the Curve Measured Using Minimally Invasive Interstitial Fluid Extraction Technology with Continuous Glucose Monitoring System in Diabetic Patients [2017 Aug;41(4)] Comparison of Glucose Area Under the Curve Measured... 2018-12-03 153
Notice : [2017 Aug;41(4)] The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis [2017 Aug;41(4)] The Effectiveness of Green Tea or Green Tea Extract... 2018-12-03 146
Notice : [2017 Aug;41(4)] Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs [2017 Aug;41(4)] Unusual Suspects in the Development of Obesity-Indu... 2018-12-03 162
197 [2017 Jun;41(3)] Satisfaction Survey on Information Technology-Based... 2017-07-06 7,594
196 [2017 Jun;41(3)] The Effect of 12 Weeks Aerobic, Resistance, and Com... 2017-07-06 7,528
195 [2017 Jun;41(3)] Impact of Gender on the Association between Low Ser... 2017-07-06 7,484
194 [2017 Jun;41(3)] Physician-Directed Diabetes Education without a Med... 2017-07-06 7,150
193 [2017 Jun;41(3)] Knowledge, Attitude, and Practice of Iranian Intern... 2017-07-06 7,108
192 [2017 Jun;41(3)] Comparison of Antidiabetic Regimens in Patients wit... 2017-07-06 7,298
191 [2017 Jun;41(3)] Diabetes Prevention in Australia: 10 Years Results ... 2017-07-06 7,106
190 [2017 Jun;41(3)] Comprehensive Approach for Managing the Older Perso... 2017-07-06 6,806
189 [2017 Apr;41(2)] A Cutoff for Age at Menarche Predicting Metabolic S... 2017-07-06 6,782
188 [2017 Apr;41(2)] Addition of Ipragliflozin to Metformin Treatment in... 2017-07-06 7,153

목록

Gets the previous 5 pages.   Go to previous page.  [1]   2   3   4   5     Go to next page. Gets the next  5 pages.